Trial intelligence / Profile preview

SVF for Skin Grafting Improvement

NCT02546882Phase 2Unknown

Sponsor
Shanghai Jiao Tong University School of Medicine
Start
Feb 2015
Primary completion
Jun 2016
Modality
Stem Cell Therapies
Countries
1
01

Overview

Phase 2, randomised, open-label trial of autologous adipose stromal vascular fraction in scar (2 arms), sponsored by Shanghai Jiao Tong University School of Medicine. Primary endpoint: Texture and colour change of the skin at 6 months. Status: unknown.

02

Drugs

autologous adipose stromal vascular fraction
03

Conditions

scar

Beyond the preview

Go deeper on NCT02546882.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02546882.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call